SymbolMBOT
NameMICROBOT MEDICAL INC.
SectorHEALTH CARE
RegionMiddle East
IndustryBiotechnology: Biological Products (No Diagnostic Substances)
Address175 DERBY ST.,BLD. 27, HINGHAM, Massachusetts, 02043, United States
Telephone+1 781 - 875-3605
Fax
Email
Websitehttps://www.microbotmedical.com
IncorporationUNDEFINED
Incorporated On
Employees
Fiscal Year
Public Since
ExchangesNASDAQ
Auditor
Audit StatusNOT PROVIDED
Reporting Status
CIK0000883975
Description

Microbot Medical Inc is a pre-clinical medical device company. It specializes in developing next generation micro-robotic medical technologies that can change the future of medicine. Their vision is to improve the quality of life of millions of patients globally by advancing micro-robotic technologies to perform surgical procedures and offer physicians and their patients less invasive and more precise solutions. The companys innovative platforms LIBERTY and Self-Cleaning Shunt SCS are in one of the fastest growing segments in healthcare. They continuously develop their technology with the goal to improve surgical outcomes worldwide. The firm presently holds domestic and global patents that strengthen their product portfolio and create barriers of entry.

Additional info from NASDAQ:
Microbot Medical Inc is a pre-clinical medical device company. It specializes in developing next generation micro-robotic medical technologies that can change the future of medicine. Their vision is to improve the quality of life of millions of patients globally by advancing micro-robotic technologies to perform surgical procedures and offer physicians and their patients less invasive and more precise solutions. The companys innovative platforms LIBERTY and Self-Cleaning Shunt SCS are in one of the fastest growing segments in healthcare. They continuously develop their technology with the goal to improve surgical outcomes worldwide. The firm presently holds domestic and global patents that strengthen their product portfolio and create barriers of entry.

2026-06-30 12:30

(80% Positive) MICROBOT MEDICAL INC. (MBOT) Announces Regulatory Update

Read more
2026-06-30 12:30

Microbot Medical® Increases Manufacturing Capacity as Demand for the LIBERTY® System Rises; Enters into Strategic Agreement with Sanmina, a Global Manufacturing Leader

Read more
2026-06-25 12:30

(70% Positive) MICROBOT MEDICAL INC. (MBOT) Announces Regulatory Update

Read more
2026-06-23 12:30

(70% Positive) MICROBOT MEDICAL INC. (MBOT) Provides Update on states for New Jersey

Read more
2026-06-23 12:30

Microbot Medical® Announces First Health System in Pennsylvania to Adopt the LIBERTY® Endovascular Robotic System

Read more
2026-06-16 12:30

(67% Positive) MICROBOT MEDICAL INC. (MBOT) Announces Clinical Development Update

Read more
2026-06-16 12:30

Microbot Medical® Enters Into an Agreement to Expand Access for America’s Veteran and Military Patient Populations

Read more
2026-06-09 12:30

(75% Positive) MICROBOT MEDICAL INC. (MBOT) Announces Regulatory Update

Read more
2026-06-09 12:30

Microbot Medical® Announces a Notable Health System as the First in Michigan to Adopt the LIBERTY® Endovascular Robotic System

Read more
2026-06-02 12:30

(99% Positive) MICROBOT MEDICAL INC. (MBOT) Announces Clinical Development Update

Read more
Trial ID Title Phase Indication Status Start Date Completion Date Source
NCT06141694 Assessment of Clin. Capabilities of LIBERTY® Endovascular Robotic System's Perf… Na Peripheral Vascular Interventions Completed 2024-07-02 2024-10-15 ClinicalTrials.gov
Total clinical trials: 1
Product Name Type Development Stage Therapeutic Area Study Status Trial ID
The LIBERTY® Robotic System Other Approved Peripheral Vascular Interventions COMPLETED NCT06141694
The LIBERTY® Robotic System DEVICE Approved Peripheral Vascular Interventions COMPLETED NCT06141694
Total products: 2